NCT04565574View on ClinicalTrials.gov

A Study to Assess the Effect of Food Intake and Drug-drug Interactions of E7090 When Co-administered With Rabeprazole or Rifampin in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

October 16, 2020

Primary Completion Date

March 31, 2021

Study Completion Date

March 31, 2021

Conditions
Healthy Participants
Interventions
DRUG

E7090

Oral tablet.

DRUG

Rabeprazole 20 mg

Rabeprazole 20 mg (2 tablets, each of 10 mg) oral tablet.

DRUG

Rifampin 600 mg

Rifampin 600 mg (4 capsules, each of 150 mg) oral capsule.

Trial Locations (1)

Unknown

Eisai trial site #1, Minatoku

All Listed Sponsors
lead

Eisai Co., Ltd.

INDUSTRY

NCT04565574 - A Study to Assess the Effect of Food Intake and Drug-drug Interactions of E7090 When Co-administered With Rabeprazole or Rifampin in Healthy Participants | Biotech Hunter | Biotech Hunter